Vivek Subbiah, Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, posted on LinkedIn:
“Exciting Nature Medicine Publication Announcement!!!
Hot off the press on this Clinical Trials Day! Thrilled to share our Nature Medicine paper: “Cancer treatment paradigms in the precision medicine era”.
- We propose 5 BOLD strategic recommendations to modernize cancer care-moving from one-size-fits-all to truly personalized interventions.
- In this work, we address the critical need to evolve beyond traditional cancer treatment approaches.
- The precision medicine revolution is transforming oncology, but fully implementing these advances requires systematic changes in how we approach treatment paradigms. Our paper outlines a roadmap for this transformation.”
Title: Cancer treatment paradigms in the precision medicine era.
Authors: Vivek Subbiah, Giuseppe Curigliano, Jason K. Sicklick, Shumei Kato, Kjetil Tasken, Arielle Medford, Damian T. Rieke, Hui-Zi Chen, Adam Wahida, Lars Buschhorn, Denis Horgan and Razelle Kurzrock
Read The Full Article at Nature Medicine.
More posts featuring Vivek Subbiah.